In postpartum hemorrhage, what blood product and dose are recommended?

Study for the BSO Protocols Test. Master key concepts with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

In postpartum hemorrhage, what blood product and dose are recommended?

Explanation:
In postpartum hemorrhage, the goal is rapid, balanced resuscitation that addresses both blood loss and coagulopathy. Whole blood is ideal because it contains red cells to carry oxygen, plasma with clotting factors, and platelets all in one product. That combination helps restore circulating volume, improve oxygen delivery, and begin correcting the coagulation system quickly. A typical starting dose is about one to two units, which provides meaningful stabilization without overwhelming the patient. If whole blood isn’t available, a guided transfusion of red blood cells, fresh frozen plasma, and platelets in a roughly 1:1:1 ratio is used to mimic the effects of whole blood and address both anemia and coagulopathy. Other options on their own tackle only part of the problem: platelets improve platelet count but don’t replace red cells or plasma factors; fresh frozen plasma fixes coagulation factor deficits but doesn’t restore oxygen-carrying capacity; cryoprecipitate increases fibrinogen but doesn’t provide red cells or a full set of coagulation factors.

In postpartum hemorrhage, the goal is rapid, balanced resuscitation that addresses both blood loss and coagulopathy. Whole blood is ideal because it contains red cells to carry oxygen, plasma with clotting factors, and platelets all in one product. That combination helps restore circulating volume, improve oxygen delivery, and begin correcting the coagulation system quickly. A typical starting dose is about one to two units, which provides meaningful stabilization without overwhelming the patient.

If whole blood isn’t available, a guided transfusion of red blood cells, fresh frozen plasma, and platelets in a roughly 1:1:1 ratio is used to mimic the effects of whole blood and address both anemia and coagulopathy.

Other options on their own tackle only part of the problem: platelets improve platelet count but don’t replace red cells or plasma factors; fresh frozen plasma fixes coagulation factor deficits but doesn’t restore oxygen-carrying capacity; cryoprecipitate increases fibrinogen but doesn’t provide red cells or a full set of coagulation factors.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy